- Published date :
-
Apr 13, 2010
- Expired date :
-
Apr 13, 2040
April 13, 2010 – Wilmington, DE – AstraZeneca (NYSE:AZN) is proud to announce that Catherine M. Bonuccelli, MD, Clinical Vice President, Respiratory & Inflammation, was awarded the Delaware Bio Service Award by the Delaware Bio Science Association.
The Delaware Bio Service Award recognizes individuals who have donated their time and talent, made financial contributions or contributed in other ways to better Delaware's life science community.
“Biosciences represent an essential element of Delaware’s economy with a great potential for continued growth,” said Dr. Bonuccelli. “AstraZeneca is just one company that benefits from the great strides the Delaware Bioscience Association has made to bridge businesses, the state government and academia on key issues that face Delaware’s dynamic biosciences community. It is the innovation of this sector that leads to real medical progress.”
Dr. Bonuccelli was honored for her leadership in developing the Delaware Bioscience Association as a self-sustaining membership organization dedicated to ensuring that Delaware maintains and strengthens its presence as a global leader in the life sciences. Her work in this area was one of several recommendations from former Governor Minner’s Task Force asked to identify what was needed to support a thriving bioscience industry in the state. Dr. Bonuccelli is also very dedicated to the local community and serves as a member of the board of several organizations such as Alfred I. duPont Hospital for Children, Delaware Biotechnology Park, and the American College of Physicians Foundation.
At AstraZeneca, Dr. Bonuccelli leads a variety of drug development projects across all phases of the product life cycle in the Respiratory and Inflammation Therapy Area. In addition to significant clinical development experience, she was most recently the Global Product Vice President for Symbicort with responsibility for product strategy and execution worldwide.
Prior to joining AstraZeneca, Dr. Bonuccelli served as Associate Professor of Pediatrics at the University of Virginia School of Medicine. There, Dr. Bonuccelli was also Associate Director of the Cystic Fibrosis Center and established a new clinical division within the Department of Pediatrics, including provision of sleep studies, documented home apnea monitoring, pulmonary function and bronchoscopy services.
The Delaware Bioscience Association is a non-profit trade association that serves its members and the State of Delaware by collaborating with other local businesses and organizations to advance the growth of the bioscience industry in Delaware and the region. Visit www.delawarebio.org for more information.
About AstraZeneca
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of $32.8 billion in 2009. In the United States, AstraZeneca is a $14.8 billion healthcare business.
For more information about AstraZeneca in the US or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com or call 1-800-AZandMe (292-6363).
Media Contacts:
- Tiffany Burke, AstraZeneca: 302-885-4995
